HIGHLIGHTS
- who: Massimo Russo and colleagues from the Department of Biomedicine, Neuroscience and Advanced Diagnostic (BIND), University of Palermo have published the paper: Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area, in the Journal: (JOURNAL) of 31/Dec/2020
- what: The aim of this work was to analyze whether current therapies prolong survival for patients affected by amyloidosis. This study examined 159 patients with pathogenic mutations in the TTR gene at the two reference centers from 1991 to 2020, 135 in Messina and 24 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.